Osborne Clarke's team routinely advises on IP law issues in patent infringement proceedings, while the regulatory expertise is called upon in matters pertaining to pharmaceutical advertising law. This is complemented by capacities at the corporate law interface, such as the advice on pharmaceutical cooperation and licensing agreements, including cross-border transactions, as well as experience in supporting digitisation projects. The project work frequently pertains to patient care and treatment in connection with healthcare platforms. AI-related topics in the medical device segment and related data protection issues are also covered, practice head Tim Reinhard is a key contact here.
Testimonials
Collated independently by Legal 500 research team.
- 'Andrea Schmoll: Very pleasant in management matters, is very aware of the specialist knowledge in her team as well as in the firm and actively involves relevant colleagues to ensure consistently high quality.'
- 'Dedicated team that works well with new inquiries.'
Key clients
- Bruker Gruppe Deutschland (Bruker EAS, Bruker HTS, Bruker BioSpin, RI Research)
- CEVEC Pharmaceuticals GmbH
- Fresenius SE
- Gerresheimer AG
- Haema AG
- PharmaDrug, Inc.
- VAMED Rehazentren Deutschland GmbH
- Grifols Deutschland GmbH
Work highlights
- Advice and support for the Bruker Group Germany on various projects, including dismissal protection procedures, realignment of the BASC division and design and implementation of a new working time and time recording system.
- Supporting Fresenius SE in the planning and implementation of a project to convert any active contractual relationships based on the old EU standard contractual clauses to the new EU standard contractual clauses.
- Advising PharmaDrug, Inc. on the sale of all shares of its German subsidiary Pharmadrug Production GmbH to Khiron Life Sciences Corp.
Practice head
The lawyer(s) leading their teams.
Tim Reinhard